Illinois Municipal Retirement Fund Sells 14,906 Shares of DaVita Inc. $DVA

Illinois Municipal Retirement Fund reduced its stake in DaVita Inc. (NYSE:DVA) by 67.4% in the 1st quarter, Holdings Channel reports. The firm owned 7,206 shares of the company’s stock after selling 14,906 shares during the period. Illinois Municipal Retirement Fund’s holdings in DaVita were worth $1,107,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Invesco Ltd. raised its position in shares of DaVita by 2.0% in the third quarter. Invesco Ltd. now owns 1,679,248 shares of the company’s stock valued at $223,122,000 after purchasing an additional 32,358 shares during the period. Morgan Stanley boosted its holdings in shares of DaVita by 5.1% during the 4th quarter. Morgan Stanley now owns 1,477,045 shares of the company’s stock worth $167,807,000 after buying an additional 71,156 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in DaVita by 114.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,190,000 shares of the company’s stock valued at $135,196,000 after buying an additional 636,191 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in DaVita by 0.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,089,100 shares of the company’s stock worth $123,733,000 after acquiring an additional 3,507 shares during the period. Finally, LSV Asset Management lifted its position in DaVita by 1.1% during the 4th quarter. LSV Asset Management now owns 936,768 shares of the company’s stock worth $106,426,000 after acquiring an additional 9,739 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

DVA has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft upgraded shares of DaVita from a “hold” rating to a “buy” rating and upped their price target for the company from $126.00 to $220.00 in a report on Wednesday, May 6th. Truist Financial boosted their price objective on DaVita from $205.00 to $250.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Weiss Ratings restated a “hold (c+)” rating on shares of DaVita in a research note on Monday, June 8th. TD Cowen raised their target price on DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a report on Monday, May 11th. Finally, Barclays upped their price target on DaVita from $194.00 to $218.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 8th. Two equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, DaVita has an average rating of “Hold” and an average target price of $216.50.

DaVita Price Performance

NYSE DVA opened at $231.56 on Thursday. The firm has a market capitalization of $14.87 billion, a price-to-earnings ratio of 21.48, a P/E/G ratio of 0.78 and a beta of 0.88. The company’s fifty day moving average is $212.06 and its two-hundred day moving average is $167.40. DaVita Inc. has a 52-week low of $101.00 and a 52-week high of $239.64.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The business had revenue of $3.42 billion during the quarter, compared to analyst estimates of $3.36 billion. During the same quarter in the prior year, the business earned $2.00 earnings per share. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, sell-side analysts expect that DaVita Inc. will post 15.07 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Kathleen Alyce Waters sold 15,405 shares of DaVita stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the sale, the insider owned 109,194 shares of the company’s stock, valued at approximately $22,756,029.60. This trade represents a 12.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Joel Ackerman sold 51,471 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the sale, the chief financial officer owned 132,434 shares in the company, valued at approximately $25,440,571.40. This represents a 27.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.90% of the company’s stock.

DaVita Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.